# Enzolytics Inc. (ENZC)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ENZC/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -188.9K | N/A | $ 996.3K | $ -118.68M |
| 2024 | $ 0 | $ -414.3K | $ 120.68M | $ 996.3K | $ -118.58M |
| 2023 | $ 134.7K | $ -4.23M | $ -599.2K | $ 1.74M | $ -4.58M |
| 2022 | $ 0 | $ -3.30M | $ -3.63M | $ 1.18M | $ -3.32M |
| 2021 | $ 237.7K | $ -477.4K | $ -1.10M | $ 431.0K | $ 9.91M |
| 2020 | $ 0 | $ -14.20M | $ 3.77M | $ 431.0K | $ 8.36M |
| 2011 | $ 31.7K | $ -699.7K | $ -351.9K | $ 141.1K | $ -690.6K |
| 2010 | $ 56.0K | $ -11.38M | $ -620.7K | $ 289.8K | $ -572.0K |
| 2009 | $ 22.3K | $ -1.47M | $ -563.1K | $ 430.5K | $ -1.33M |
| 2008 | $ 7.1K | $ -490.6K | $ -31.4K | $ 403.7K | $ -709.8K |
| 2007 | $ 0 | $ -41.9K | $ -493.3K | $ 355.8K | $ -302.3K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.01 |
| Liabilities / Eq | -2.70 |
| Current Ratio | 0.63 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / FCF | 0.05 |

## Other views

- [Metrics](https://sponda.capital/en/ENZC.md)
- [Charts](https://sponda.capital/en/ENZC/charts.md)
- [Compare](https://sponda.capital/en/ENZC/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.